Aug 14, 2020
Soligenix Announces Recent Accomplishments And Second Quarter 2020 Financial Results
Jun 18, 2020
Almac Discovery to Present Updates on Key Oncology Programmes at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
Jun 09, 2020
Soligenix to Present at the MedInvest Infectious Disease and Immunology Investor Conference
Jun 02, 2020
Collagen Peptides Market Worth $795 Million by 2025 - Exclusive Report by MarketsandMarkets(TM)
Jun 02, 2020
Moleculin Announces Emory University Clinical Trial of WP1066 Begins Enrollment
Jun 01, 2020
San Diego Top Doctor Collaborates with Therapeutic Solutions International to Report QuadraMune(TM) Immune Boosting Data in Clinical Trial
Jun 01, 2020
Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19
May 31, 2020
(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies
May 19, 2020
Aalto Bio Reagents Launches New Recombinant Eukaryotic SARS-CoV-2, S1-S2 Spike Proteins for Improved Diagnostic Testing of COVID-19
May 19, 2020
Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases
May 19, 2020
Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy(TM) (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies
May 15, 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
May 13, 2020
Gore PharmBIO Introduces 9.0 mL Protein Capture Device To Improve Throughput And Productivity In Bioprocessing Process Development
May 11, 2020
Soligenix Announces Publication of Correlates of Immune Protection for the RiVax® Ricin Toxin Vaccine
May 07, 2020
Soligenix Receives $840,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
May 05, 2020
Journal of Neuroinflammation Article Shows ZyVersa's Inflammasome Inhibitor, IC 100, Improves Functional Outcomes in an Animal Model of Multiple Sclerosis
Apr 27, 2020
Eiger BioPharmaceuticals Announces EMA Validation of Lonafarnib MAA for Treatment of Progeria and Progeroid Laminopathies
Apr 22, 2020
Fibrinogen Market Growth Analysis to 2023 - Featuring Key Players: Shanghai XinXing Medical, CSL Behring, Greencross, Johnson & Johnson, Baxter, LFB Group, & ProFibrix BV | Radiant Insights, Inc.
Apr 06, 2020
HEMA Biologics(TM) Announces FDA Approval of SEVENFACT® [coagulation factor VIIa (recombinant)-jncw] for Treatment and Control of Bleeding Episodes Occurring in Adult and Adolescent Hemophilia A and B Patients with Inhibitors
Apr 01, 2020
FDA Approves Additional Treatment for Adults and Adolescents with Hemophilia A or B and Inhibitors